.png){kind=icon}
.png){kind=icon}
Return
Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety
.png){kind=icon}
PRE
AI
J
DOI：10.5217/ir.2026.00070.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a post hoc analysis of safety and effectiveness in older (>= 65 years) and younger (<65 years) patients (Intest Res 2026;24:214-224)
Journal
IF:
3.9
Papers:
371
Citations:
1.6K
Organization
Cited Papers